Femasys FEMY
NASDAQ FEMY
$2.73 +0.02 (+0.74%)
At close: Aug 20, 2026 · 4:00 PM EDT

Femasys (FEMY) Non-Current Debt (2020)

Femasys' (FEMY) quarterly Non-Current Debt came in at $182490.0 in Q4 2020.

Femasys (FEMY) Non-Current Debt (2020) Analysis & Trends

Femasys (FEMY) has 1 years of Non-Current Debt data on file, last reported at $182490.0 in Q4 2020.

  • Quarterly Non-Current Debt changed N/A year-over-year to $182490.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $182490.0 (changed N/A YoY) and the FY2020 annual result came in at $182490.0, changed N/A from the prior year.
  • Non-Current Debt steadied at $182490.0 in Q4 2020.
  • In the past five years, Non-Current Debt ranged from a high of $182490.0 in Q4 2020 to a low of $182490.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn -
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn 13.51 Bn
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn 4.15 Bn
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn 399.42 Mn
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn 12.55 Bn
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn 202.90 Mn
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn 4.57 Bn
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn 1.86 Bn
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn 8.62 Bn
10 Femasys 8.98 Mn 7.54 Mn 189,391.00 -

Historic Data

Download Data
DateValue
Dec 31, 2020 182,490.00